EUROPE CARDIOVASCULAR ULTRASOUND MARKET 2022-2028

Description

EUROPE CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK

CRI’s report on Europe’s cardiovascular ultrasound market estimates that it would grow in terms of revenue, with a CAGR of 6.03% in the forecast period from 2022 to 2028. Spain, Germany, France, Italy, the United Kingdom, and Rest of Europe are assessed in the market in this region.
Heart and circulatory diseases are responsible for nearly 25% of all deaths in the United Kingdom.

Approximately 7.6 million individuals (4 million men and 3.6 million women) in the nation have reported having a heart or circulatory disease. The most common type of heart disease is coronary heart disease (CHD). It is a leading cause of cardiac arrests and resulting mortality in both men and women.

The alarming prevalence rate of these diseases has enhanced the demand for cardiovascular ultrasound devices in the UK. This has prompted key players, such as Siemens Healthineers, GE Healthcare, and others, to offer technologically advanced echocardiography machines to diagnose and examine these conditions efficiently.

CVDs are also becoming increasingly prevalent in France. These ailments are largely affecting the younger segments of the population, and are the second leading cause of mortality in the country, at present. According to the statistics, approximately 63,181 people in the nation died from (CHD) in 2020, accounting for 13.22% of total deaths.

This has accelerated the demand for cardiovascular ultrasound systems to effectively detect these illnesses on time and aid the treatment process. The increased adoption of these equipment is expected to foster the cardiovascular ultrasound market’s growth in the years to come.

COMPETITIVE OUTLOOK

A few eminent players in the cardiovascular ultrasound market include Telemed Ultrasound Medical Systems, Samsung Medison Co Ltd, Clarius, Esaote S.p.A., Viatom Technology Co, Fujifilm Holdings Corporation, Dawei Medical, and Lanmage.

TABLE OF CONTENTS

1. EUROPE CARDIOVASCULAR ULTRASOUND MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE CARDIOVASCULAR ULTRASOUND MARKET
2.2. KEY INSIGHTS
2.2.1. EMERGENCE OF ARTIFICIAL INTELLIGENCE (AI)
2.2.2. STRAIN IMAGING HAS SEEN A GRADUAL INCREASE
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY IMPACT ANALYSIS
2.4.1. QUALITY
2.4.2. DURABILITY
2.4.3. PRICE
2.4.4. TECHNOLOGY
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. KEY MARKET STRATEGIES
2.8.1. PRODUCT LAUNCHES
2.8.2. ALLIANCES
2.9. MARKET DRIVERS
2.9.1. INCREASE IN CARDIOVASCULAR DISEASE CASES
2.9.2. ADVANCEMENTS IN TECHNOLOGY
2.10. MARKET CHALLENGES
2.10.1. LACK OF AWARENESS AMONG PATIENTS
2.10.2. NEED TO ABIDE BY STRINGENT REGULATIONS
2.11. MARKET OPPORTUNITIES
2.11.1. RAPID EXPANSION OF POINT-OF-CARE ULTRASOUND (POCUS)
2.11.2. RAPID GROWTH OF FETAL ECHOCARDIOGRAPHY
3. EUROPE CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY DISPLAY
3.1. BLACK AND WHITE
3.2. COLORED
4. EUROPE CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TECHNOLOGY
4.1. 2D
4.2. 3D/4D
4.3. DOPPLER
5. EUROPE CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TYPE
5.1. TRANSTHORACIC ECHOCARDIOGRAPHY
5.2. FETAL ECHOCARDIOGRAPHY
5.3. TRANSESOPHAGEAL ECHOCARDIOGRAPHY
5.4. OTHER TYPES
6. EUROPE CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY END-USER
6.1. HOSPITALS
6.2. DIAGNOSTIC CENTERS
6.3. AMBULATORY CARE CENTERS
6.4. OTHER END-USERS
7. EUROPE CARDIOVASCULAR ULTRASOUND MARKET – COUNTRY OUTLOOK
7.1. UNITED KINGDOM
7.2. GERMANY
7.3. FRANCE
7.4. SPAIN
7.5. ITALY
7.6. REST OF EUROPE
8. COMPETITIVE LANDSCAPE
8.1. GE HEALTHCARE
8.2. PHILIPS HEALTHCARE
8.3. SIEMENS HEALTHINEERS
8.4. CANON MEDICAL CORP
8.5. FUJIFILM HOLDINGS CORPORATION
8.6. SAMSUNG MEDISON CO LTD
8.7. ESAOTE S.P.A.
8.8. MINDRAY MEDICAL INTERNATIONAL LIMITED
8.9. VIATOM TECHNOLOGY CO
8.10. LANMAGE
8.11. DAWEI MEDICAL
8.12. ZONCARE
8.13. LELTEK INC
8.14. TELEMED ULTRASOUND MEDICAL SYSTEMS
8.15. CLARIUS
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF ALLIANCES
TABLE 6: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 7: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2022-2028 (IN $ MILLION)
TABLE 8: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2022-2028 (IN $ MILLION)
TABLE 9: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 10: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2022-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2021 & 2028 (IN %)
FIGURE 5: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY BLACK AND WHITE, 2022-2028 (IN $ MILLION)
FIGURE 6: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY COLORED, 2022-2028 (IN $ MILLION)
FIGURE 7: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2021 & 2028 (IN %)
FIGURE 8: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY 2D, 2022-2028 (IN $ MILLION)
FIGURE 9: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY 3D/4D, 2022-2028 (IN $ MILLION)
FIGURE 10: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY DOPPLER, 2022-2028 (IN $ MILLION)
FIGURE 11: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2021 & 2028 (IN %)
FIGURE 12: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSTHORACIC ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 13: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY FETAL ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 14: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 15: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER TYPES, 2022-2028 (IN $ MILLION)
FIGURE 16: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 17: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY HOSPITALS, 2022-2028 (IN $ MILLION)
FIGURE 18: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY DIAGNOSTIC CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 19: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY AMBULATORY CARE CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 20: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)
FIGURE 21: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 22: UNITED KINGDOM CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: GERMANY CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: FRANCE CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 25: SPAIN CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: ITALY CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 27: REST OF EUROPE CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)